E

Enlivex Therapeutics Ltd

D
ENLV
USD
-0.07
(-4.5161%)
Market Closed
9,363.00
Volume
-0.7
EPS
-
Div Yield
-1.254237
P/E
31,680,925.88
Market Cap
Today
-4.5161%
1 Week
-5.128%
1 Month
17.460%
6 Months
-63.636%
12 Months
-20.000%
Year To Date
-45.185%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ANAB
0.87
(2.3783%)
USD
A
AQST
0.255
(5.1567%)
USD
A
ARDX
0.085
(1.4382%)
USD
A
AVDL
-0.05
(-0.3666%)
USD
CI
CI
1.9
(0.5346%)
USD
VRTX
VRTX
3.93
(0.8292%)
USD
O
OPK
-0.03
(-1.8519%)
USD
G
GLPG
0.26
(0.8598%)
USD
C
CRBP
2.21
(4.4646%)
USD

Title:
Enlivex Therapeutics Ltd

Sector:
Healthcare
Industry:
Biotechnology
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Do you need help or have a question?
Contact Us